|
ITGB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65739999502534E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.44539999968885E-08 |
| Normal-vs-Stage2 |
8.983900E-03 |
| Normal-vs-Stage3 |
1.51767999999608E-05 |
| Normal-vs-Stage4 |
3.804100E-04 |
| Stage1-vs-Stage2 |
3.060000E-01 |
| Stage1-vs-Stage3 |
9.793400E-01 |
| Stage1-vs-Stage4 |
3.097000E-01 |
| Stage2-vs-Stage3 |
4.286000E-01 |
| Stage2-vs-Stage4 |
8.806400E-01 |
| Stage3-vs-Stage4 |
4.346400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.83729994843674E-09 |
| Normal-vs-AfricanAmerican |
1.759600E-02 |
| Normal-vs-Asian |
1.167950E-01 |
| Caucasian-vs-AfricanAmerican |
1.171970E-01 |
| Caucasian-vs-Asian |
5.955800E-01 |
| AfricanAmerican-vs-Asian |
2.681800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44389999956474E-08 |
| Normal-vs-Female |
3.3108000000448E-06 |
| Male-vs-Female |
3.707400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.063100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.85309999567451E-08 |
| Normal-vs-Age(61-80Yrs) |
6.79070000009219E-07 |
| Normal-vs-Age(81-100Yrs) |
2.462200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.939800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.418200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.218400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.808600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.056000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.398190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.479500E-03 |
| Normal-vs-Grade 2 |
1.40680000981774E-09 |
| Normal-vs-Grade 3 |
1.216630E-04 |
| Normal-vs-Grade 4 |
5.961000E-04 |
| Grade 1-vs-Grade 2 |
2.056600E-01 |
| Grade 1-vs-Grade 3 |
6.753900E-02 |
| Grade 1-vs-Grade 4 |
3.048000E-02 |
| Grade 2-vs-Grade 3 |
5.084400E-03 |
| Grade 2-vs-Grade 4 |
1.050800E-01 |
| Grade 3-vs-Grade 4 |
7.539600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.32859999668611E-08 |
| Normal-vs-ccB subtype |
2.43639999952805E-07 |
| ccA subtype-vs-ccB subtype |
7.921200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.86100000030021E-07 |
| Normal-vs-N1 |
3.339700E-02 |
| N0-vs-N1 |
2.875600E-01 |
|
|
